{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06299163",
            "orgStudyIdInfo": {
                "id": "NB-NM032-2668-101"
            },
            "organization": {
                "fullName": "Numab Therapeutics AG",
                "class": "INDUSTRY"
            },
            "briefTitle": "NM32-2668 in Adult Patients With Selected Advanced Solid Tumors",
            "officialTitle": "A Phase 1 Study of NM32-2668 (Anti-ROR1/CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients With Selected Advanced Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "in-adult-patients-with-selected-advanced-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-26",
            "studyFirstSubmitQcDate": "2024-03-01",
            "studyFirstPostDateStruct": {
                "date": "2024-03-07",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-07",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Numab Therapeutics AG",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a first-in-human, open-label, multi-center, Phase 1, dose-escalation study with expansion cohorts to evaluate NM32-2668 for safety and immunogenicity, to determine the maximal tolerated dose and recommended Phase 2 dose, define the pharmacokinetics, to explore the pharmacodynamics, and to obtain preliminary evidence of the clinical activity in adult patients with selected advanced solid tumors."
        },
        "conditionsModule": {
            "conditions": [
                "Ovarian Carcinoma",
                "Fallopian Tube Carcinoma",
                "Peritoneal Carcinoma",
                "Endometrial Cancer",
                "Adenocarcinoma of Lung",
                "Triple Negative Breast Cancer",
                "Liposarcoma",
                "Leiomyosarcoma",
                "Mesothelioma, Malignant",
                "Adenocarcinoma - Gastroesophageal Junction (GEJ)",
                "Adenocarcinoma of the Stomach",
                "Melanoma, Malignant",
                "Renal Cell Carcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 180,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "NM32-2668",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Biological: NM32-2668"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "NM32-2668",
                    "description": "Anti-ROR1/Anti-Cluster of Differentiation 3 (CD3)/Anti-Human Serum Albumin (HSA) Tri-Specific Antibody",
                    "armGroupLabels": [
                        "NM32-2668"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Dose Limiting Toxicities (DLTs)",
                    "timeFrame": "Through 28 days post-infusion"
                },
                {
                    "measure": "Number of participants with treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs) as assessed by CTCAE v5.0 / ASTCT (for Cytokine Release Syndrome [CRS])",
                    "timeFrame": "Through 50 days post-final dose administration"
                },
                {
                    "measure": "Frequency of dose interruptions/reductions",
                    "timeFrame": "Up to 12 treatment cycles or through treatment discontinuation, whichever occurs first"
                },
                {
                    "measure": "Duration of dose interruptions/reductions",
                    "timeFrame": "Up to 12 treatment cycles or through treatment discontinuation, whichever occurs first"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Assessment of the maximum observed serum concentration (Cmax)",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of the the minimum observed serum concentration (Cmin)",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Time from dosing at which maximum observed serum concentration is apparent (Tmax)",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of the terminal phase (apparent elimination) rate constant (\u03bbz)",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of the elimination half-life (t\u00bd)",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of the area under the serum concentration-time curve extrapolated from the last quantifiable concentration to infinity (AUC[0-infinity])",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of the area under serum concentration-time curve over dosing interval (AUCtau)",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of clearance (CL) of NM32-2668 in serum",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of the volume of distribution (Vd) of NM32-2668 in serum",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of accumulation ratios of Cmax (ARcmax) of NM32-2668 in serum",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of accumulation ratios of Cmin (ARcmin) of NM32-2668 in serum",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Assessment of accumulation ratios of AUC (ARauc) of NM32-2668 in serum",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Frequency of specific anti-drug antibodies (ADAs) to NM32-2668",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Concentration of specific ADAs to NM32-2668",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Incidence of specific ADAs by category to NM32-2668",
                    "timeFrame": "From date of randomization until end of treatment, assessed for up to 336 days (i.e., 12 treatment cycles) or through treatment discontinuation"
                },
                {
                    "measure": "Best Overall Response (BOR) according to RECIST 1.1",
                    "timeFrame": "From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed for up to 30 days following last dose of study treatment"
                },
                {
                    "measure": "Overall Response Rate (ORR) according to RECIST 1.1",
                    "timeFrame": "From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed for up to 30 days following last dose of study treatment"
                },
                {
                    "measure": "Disease Control Rate (DCR) according to RECIST 1.1",
                    "timeFrame": "From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed for up to 30 days following last dose of study treatment"
                },
                {
                    "measure": "Progression-free Survival (PFS) according to RECIST 1.1",
                    "timeFrame": "From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed through study completion (on average, 1 year after last treatment)"
                },
                {
                    "measure": "Time to Response (TTR) according to RECIST 1.1",
                    "timeFrame": "From date of randomization until the date of first documented treatment response according to RECIST 1.1"
                },
                {
                    "measure": "Duration of Response (DOR) according to RECIST 1.1",
                    "timeFrame": "From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed through study completion (on average, 1 year after last treatment)"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "timeFrame": "From date of randomization until the date of death from any cause, assessed through study completion (on average, 1 year after last treatment)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with histologically confirmed, advanced-stage protocol-specified solid tumors.\n* Confirmed ROR1 tumor expression.\n* Patients who have undergone at least one prior systemic therapy and have radiologically or clinically determined progressive disease during or after most recent line of therapy, and for whom no further standard therapy is available, or who are intolerable or have medical contraindications to standard therapy.\n\nExclusion Criteria:\n\n* Prior treatment with any agent targeting ROR1 or prior treatment with a CD3 T-cell engaging therapy.\n* Prior treatment with chimeric antigen receptor (CAR) cell therapy within 90 days prior to first dose of NM32-2668.\n* Systemic anti-neoplastic therapy within five half-lives or 21 days, whichever is shorter, prior to first dose of NM32-2668.\n* Wide-field radiotherapy (\\> 30% of marrow-bearing bones) within 28 days, or focal radiation for analgesic purpose or for lytic lesions at risk of fracture within 14 days prior to first dose of NM32-2668, or no recovery from side effects of such prior interventions.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Martin Stern, MD",
                    "role": "CONTACT",
                    "phone": "+41 44 533 2292",
                    "email": "clinicaltrials@numab.com"
                }
            ],
            "locations": [
                {
                    "facility": "USC Norris Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jacob thomas",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Jacob thomas",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Cleveland Clinic",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Regina Yu",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Dale Shepard",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15232",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Heather Jandecka",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Jason Luke",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                },
                {
                    "facility": "Lifespan Cancer Institute at Rhode Island Hospital",
                    "status": "RECRUITING",
                    "city": "Providence",
                    "state": "Rhode Island",
                    "zip": "02903",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Benedito A. Carneiro, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Benedito A. Carneiro, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.82399,
                        "lon": -71.41283
                    }
                },
                {
                    "facility": "Mary Crowley Cancer Research",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75230",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Douglas W. Orr, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Douglas W. Orr, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000008545",
                    "term": "Melanoma"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                },
                {
                    "id": "D000064726",
                    "term": "Triple Negative Breast Neoplasms"
                },
                {
                    "id": "D000008654",
                    "term": "Mesothelioma"
                },
                {
                    "id": "D000086002",
                    "term": "Mesothelioma, Malignant"
                },
                {
                    "id": "D000007890",
                    "term": "Leiomyosarcoma"
                },
                {
                    "id": "D000008080",
                    "term": "Liposarcoma"
                },
                {
                    "id": "D000077192",
                    "term": "Adenocarcinoma of Lung"
                },
                {
                    "id": "D000096142",
                    "term": "Melanoma, Cutaneous Malignant"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000018358",
                    "term": "Neuroendocrine Tumors"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                },
                {
                    "id": "D000018326",
                    "term": "Nevi and Melanomas"
                },
                {
                    "id": "D000012878",
                    "term": "Skin Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000001943",
                    "term": "Breast Neoplasms"
                },
                {
                    "id": "D000001941",
                    "term": "Breast Diseases"
                },
                {
                    "id": "D000000236",
                    "term": "Adenoma"
                },
                {
                    "id": "D000018301",
                    "term": "Neoplasms, Mesothelial"
                },
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000010997",
                    "term": "Pleural Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000009379",
                    "term": "Neoplasms, Muscle Tissue"
                },
                {
                    "id": "D000018204",
                    "term": "Neoplasms, Connective and Soft Tissue"
                },
                {
                    "id": "D000012509",
                    "term": "Sarcoma"
                },
                {
                    "id": "D000018205",
                    "term": "Neoplasms, Adipose Tissue"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1687",
                    "name": "Adenocarcinoma of Lung",
                    "asFound": "Adenocarcinoma of Lung",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M10902",
                    "name": "Leiomyosarcoma",
                    "asFound": "Leiomyosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12974",
                    "name": "Ovarian Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11080",
                    "name": "Liposarcoma",
                    "asFound": "Liposarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5548",
                    "name": "Carcinoma, Renal Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M11528",
                    "name": "Melanoma",
                    "asFound": "Melanoma, Malignant",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30373",
                    "name": "Triple Negative Breast Neoplasms",
                    "asFound": "Triple Negative Breast Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1704",
                    "name": "Carcinoma, Ovarian Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M11634",
                    "name": "Mesothelioma",
                    "asFound": "Mesothelioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2537",
                    "name": "Mesothelioma, Malignant",
                    "asFound": "Mesothelioma, Malignant",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrial Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M3212",
                    "name": "Melanoma, Cutaneous Malignant",
                    "asFound": "Melanoma, Malignant",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M20495",
                    "name": "Neuroendocrine Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12448",
                    "name": "Nevus, Pigmented",
                    "relevance": "LOW"
                },
                {
                    "id": "M12446",
                    "name": "Nevus",
                    "relevance": "LOW"
                },
                {
                    "id": "M20470",
                    "name": "Nevi and Melanomas",
                    "relevance": "LOW"
                },
                {
                    "id": "M15681",
                    "name": "Skin Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5218",
                    "name": "Breast Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3591",
                    "name": "Adenoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20445",
                    "name": "Neoplasms, Mesothelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M13887",
                    "name": "Pleural Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M20350",
                    "name": "Neoplasms, Connective and Soft Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M15327",
                    "name": "Sarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20351",
                    "name": "Neoplasms, Adipose Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "T3520",
                    "name": "Lung Adenocarcinoma",
                    "asFound": "Adenocarcinoma of Lung",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3367",
                    "name": "Leiomyosarcoma",
                    "asFound": "Leiomyosarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4352",
                    "name": "Ovarian Cancer",
                    "relevance": "LOW"
                },
                {
                    "id": "T3479",
                    "name": "Liposarcoma",
                    "asFound": "Liposarcoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4906",
                    "name": "Renal Cell Carcinoma",
                    "asFound": "Renal Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1341",
                    "name": "Clear Cell Renal Cell Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T4354",
                    "name": "Ovarian Epithelial Cancer",
                    "relevance": "LOW"
                },
                {
                    "id": "T2189",
                    "name": "Fallopian Tube Cancer",
                    "asFound": "Fallopian Tube Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3584",
                    "name": "Malignant Mesothelioma",
                    "asFound": "Mesothelioma, Malignant",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4091",
                    "name": "Neuroendocrine Tumor",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T5284",
                    "name": "Soft Tissue Sarcoma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M9662",
                    "name": "Altretamine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}